Target drug for treating lung cancer and applications thereof

Abstract

The invention discloses a target drug for treating lung cancer and applications thereof. Through long term research, for the first time, the inventor finds that aluminum sulfate can recognize the normal tissues and cancer tissues of human body, can change the physiological features of cancer cells, can inhibit cancer cells from secreting multiple proteases, and inhibits the metabolism of mitochondria of cancer cells. The drug can treat cancers. The drug can be combined with the DNA of cancer cells to promote the DNA cleavage, glycoprotein on the cell surface can be rapidly astringed and agglomerated, the structure of proteins on the cell surface is effectively changed, the signal channel is obstructed, the cell microstructure is changed, the drug combines with succinodehydrogenase in cellmitochondria, the proliferation and migration of cancer cells are controlled effectively, and the cancer cell inhibition rate is as high as 99.8 to 99.9% or even 100%. The side effect of aluminum sulfate is small, the safety is high, the oral administration has the advantages of low dosage, rapid effect, and short treatment course; the tumor size can be reduced rapidly, the apoptosis is induced, the proliferation is inhibited, finally the cancer cells fall off in fragments, and the drug has an important meaning for lung cancer treatment.

Description

Technical field [0001] The present invention relates to a new application of a compound, in particular to a drug for targeted treatment of lung cancer and its application. Background technique [0002] According to the analysis of the results of the National Cancer Registry in 2013, the incidence of cancer in China was 235 per 100,000, with lung cancer and breast cancer ranking the first among men and women respectively. The incidence of cancer in China has been on the rise in the past decade. [0003] In 2012, the prevalence of hypertension among adults aged 18 and over was 25.2%, and the prevalence of diabetes was 9.7%. Compared with 2002, the prevalence rate is on the rise. The prevalence of chronic obstructive pulmonary disease in people 40 years and older is 9.9%. [0004] In 2012, the national mortality rate from chronic diseases was 533 / 100,000, accounting for 86.6% of the total deaths. Cardiovascular and cerebrovascular diseases, cancer and chronic respiratory diseases are ...

AI Technical Summary

Problems solved by technology

Further research in the later period showed that compound aluminum sulfate injection has a certain therapeutic

Images